Safety and Tolerability of the Vaginal Gel PRO 2000/5

NCT00006207 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: PRO 2000

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]